Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AstraZeneca
Pharmaceuticals
GSK
Pfizer
Novo Nordisk
Johnson and Johnson
Roche
Zoetis
Eli Lilly
Novartis
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

In the last 2 hours

AstraZeneca reprimanded over LinkedIn likes once again FiercePharma 11:39

In the last 4 hours

ADA: AZ reveals oral GLP-1 data in obesity, diabetes pharmaphorum 10:59

Earlier Today

Encouraging trial results for AstraZeneca's new weight-loss pill France 24 03:08

Advertisement

Advertisement

Yesterday

ADA 2026: AstraZeneca Advances Oral GLP-1 Elecoglipron Into Phase III After Positive Trial Data Scrip Pharma Intelligence 21:49 Mon, 08 Jun

expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 21:40 Mon, 08 Jun

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 21:37 Mon, 08 Jun

Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 21:29 Mon, 08 Jun

STAT Plus: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials STAT 21:25 Mon, 08 Jun

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio AstraZeneca (Press Release) 21:22 Mon, 08 Jun

Leica Biosystems announces expansion of collaboration European Pharmaceutical Manufacturer 17:09 Mon, 08 Jun

Friday

AstraZeneca Stresses Interconnected Disease Strategy In CVRM Scrip Pharma Intelligence 22:30 Fri, 05 Jun

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge? Simply Wall St 22:24 Fri, 05 Jun

Advancing Spatial Multiomics for Discovery: From Promise to Practice Drugs Discovery Online 18:58 Fri, 05 Jun

NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History PR Newswire (Press Release) 13:57 Fri, 05 Jun

MSD’s Enflonsia approval starts 2-way race in Korea's infant RSV prevention market Korea Biomedical Review 09:00 Fri, 05 Jun

Advertisement

Thursday

Here’s what to know about the new Ebola vaccine being fast-tracked The Independent 17:02 Thu, 04 Jun

Low-dose Zoladex won’t be available in Australia from November. What might that mean for you? The Conversation (AU) 08:41 Thu, 04 Jun

Wednesday

Life-saving breast cancer and endometriosis drug to be discontinued ABC Online 19:54 Wed, 03 Jun

Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum? Zacks 16:11 Wed, 03 Jun

Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics PR Newswire (Press Release) 13:07 Wed, 03 Jun

Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions Proactive Investors (UK) 11:42 Wed, 03 Jun

From sickness to prevention: What will it take to prevent long-term respiratory disease? Health Service Journal 07:07 Wed, 03 Jun

Former AstraZeneca research base could become private healthcare facility Cheshire Live 06:19 Wed, 03 Jun

ELRIG unveils keynote speakers for Drug Discovery 2026 News-Medical.Net 05:27 Wed, 03 Jun

In the last month

ASCO26: After negative adcomm, AZ builds case for oral SERD pharmaphorum 16:04 Tue, 02 Jun

Camizestrant combination delayed time to first progression by 55% and to second progression by 37% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumour mutation in SERENA-6 trial AstraZeneca (Press Release) 13:21 Tue, 02 Jun

CelLBxHealth and AstraZeneca sign Master Services Agreement Manufacturing Chemist 11:27 Tue, 02 Jun

ASCO26: AZ triplet makes waves in frontline liver cancer pharmaphorum 10:09 Tue, 02 Jun

ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do Proactive Investors (UK) 15:06 Mon, 01 Jun

ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer FiercePharma 13:34 Mon, 01 Jun

Imfinzi plus Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial AstraZeneca (Press Release) 13:04 Mon, 01 Jun

ASCO26: Could AL amyloidosis see a new crop of therapies? pharmaphorum 12:05 Mon, 01 Jun

FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy Pharmaceutical Technology 10:20 Mon, 01 Jun

ASCO26: AstraZeneca’s light chain amyloidosis shows subgroup benefit after Phase III trial Clinical Trials Arena 16:38 Fri, 29 May

US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial Proactive Investors (UK) 15:40 Fri, 29 May

CelLBxHealth enters service agreement with AstraZeneca, shares pop ShareCast 14:21 Fri, 29 May

Nucs AI Announces Collaboration to Develop AI-driven Response Prediction for Next-Generation Therapeutic Radioconjugates PR Newswire (Press Release) 13:30 Fri, 29 May

Ahead of ASCO data drop, AZ gets key Imfinzi approval pharmaphorum 11:11 Fri, 29 May

CelLBxHealth shares jump 36% after master services agreement with AstraZeneca Proactive Investors (UK) 09:03 Fri, 29 May

Astrazeneca's Imfinzi receives green light from US FDA ShareCast 08:24 Fri, 29 May

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis